Explore baxter.com

This global site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative

Renal Care

Therapies

We deliver and support renal therapies across the continuum of care, including the innovative HDx.

Therapies
  • Acute Therapy

    Organ support and blood purification therapies are essential to improving patient outcomes in the ICU.

  • Peritoneal Dialysis

    Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve renal patients' clinical outcomes and increase lifestyle flexibility.

  • Hemodialysis

    Hemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.

  • HDx Therapy

    HDx - also known as expanded hemodialysis - is an innovative therapy that effectively targets the removal of large middle molecules.

Products

Learn more about Baxter’s key products for Renal Care – across the continuum of care.

Data & Insights

Groundbreaking research and inspirational patient stories.

  • Clinical Data

    Explore the research enabling innovative Renal Care.

  • Stories

    Patients’ journeys inspire our work and drive our commitment.

  • Resource Library

    Access resources for Baxter’s broader Renal Care portfolio.

Clinical Data

Clinical research lies at the heart of who we are. Baxter uses scientific evidence systematically, and transparently, to inform the development of new and state-of-the-art solutions for patients around the world. Here you can find various studies, white papers and articles concerning important topics across the wide range of therapy areas served by Baxter. 

clinical-data-module-image2.png
Clinical Data – PD •

Remote Patient Management technology enhances the experience of Automated Peritoneal Dialysis

The flexibility that Peritoneal Dialysis (PD) offers renal patients allows them to maintain their lifestyle and independence. When Automated PD is combined with Remote Patient Monitoring, the flexibility is further enhanced and is associated with the potential to improve clinical outcomes and adherence.

Read More

A Focus on Clinical Research

HDx

Improved β2-Microglobulin and Phosphorous Removal with Expanded Hemodialysis and Online Hemodiafiltration versus High-Flux Hemodialysis: A Cross-Over Randomized Clinical Trial

View resource
HDx

Comparison of the medium cutoff dialyzer and postdilution hemodiafiltration on the removal of small and middle molecule uremic toxins

View resource
HDx

#2513 Effect of hemodialysis with medium cut-off versus high-flux membranes on endothelial function of chronic kidney disease patients

View resource
HDx

#2668 Superior biocompatibility of regional citrate anticoagulation compared to heparin during expanded hemodialysis with Theranova membrane

View resource
HDx

#3230 Characteristics of protein loss with medium cut-off membranes compared to high flux membranes

View resource
HDx

#3472 Preliminary data from mother HDx study: a multicentre open-label RCT study to explore the morbimortality with the Theranova HDx vs OL-HDF

View resource
HDx

#6648 Long term effect of medium cut-off dialyzer on middle uremic toxins

View resource
HDx

Medium Cut-Off versus Low-Flux Dialyzers in Hemodialysis Patients with COVID-19: Clinical Outcomes and Reduction in Interleukin-6

View resource
HDx

On the balance between albumin loss and removal of middle molecules in dialyzers

View resource
HDx

Impact of Single Hemodialysis Treatment on immune Cell Subpopulations

View resource
HDx

Rationale for a New Classification of Solutes of Interest in Chronic Kidney Disease and Hemodialysis

View resource
HDx

Successful pregnancy in a hemodialysis patient with primary hyperoxaluria type 1

View resource